Nucleocapsid-specific antibodies as a correlate of protection against SARS-CoV-2 reinfection in children

for the sKIDS Investigation team

Research output: Contribution to journalLetterpeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)267-269
Number of pages3
JournalJournal of Infection
Volume87
Issue number3
DOIs
Publication statusPublished - Sept 2023

Bibliographical note

Funding Information:
sKIDs Investigation Team: Shazaad Ahmad, MRCPath (Manchester University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UK); Felicity Aiano, MSc (Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London, UK); Gayatri Amirthalingam, MFP (Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London, UK); Frances Baawuah, MRCP (Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London, UK); Joanne Beckmann, MRCPCH(UK) (East London NHS Foundation Trust, 9 Allie Street, London E1 8DE, UK); Andrew J Brent, FRCP (Oxford University Hospitals NHS Foundation Trust, Old Road, Oxford OX3 7HE; University of Oxford, Wellington Square, Oxford OX1 2JD, UK); Bernadette Brent, MD (Oxford University Hospitals NHS Foundation Trust, Old Road, Oxford OX3 7HE; University of Oxford, Wellington Square, Oxford OX1 2JD, UK); Kevin E Brown, FRCPath (Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London, UK); Joanna Garstang, MBCHB (Birmingham Community Healthcare NHS Trust, Holt Street, Aston B7 4BN, UK); Ifeanyichukwu O. Okike, PhD FRCPCH (UK) (Derbyshire Children's hospital (University hospitals of Derby and Burton NHS Foundation Trust), Uttoxeter New Road, Derby, DE22 3NE, UK); Mary E Ramsay, FFPH (Immunisation and Vaccine Preventable Diseases Department, UK Health Security Agency, London, UK). This study was funded by the Medical Research Council UK Coronavirus Immunology Consortium (UK-CIC, MR/V028448/1) and the National Core Studies (NCS) programme (MC_PC_20031). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Funding Information:
This study was funded by the Medical Research Council UK Coronavirus Immunology Consortium (UK-CIC, MR/V028448/1) and the National Core Studies (NCS) programme (MC_PC_20031). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Cite this